Literature DB >> 16575519

The role of sialic acid in human polyomavirus infections.

Gretchen V Gee1, Aisling S Dugan, Natia Tsomaia, Dale F Mierke, Walter J Atwood.   

Abstract

JC virus (JCV) and BK virus (BKV) are human polyomaviruses that infect approximately 85% of the population worldwide [1,2]. JCV is the underlying cause of the fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML), a condition resulting from JCV induced lytic destruction of myelin producing oligodendrocytes in the brain [3]. BKV infection of kidneys in renal transplant recipients results in a gradual loss of graft function known as polyomavirus associated nephropathy (PVN) [4]. Following the identification of these viruses as the etiological agents of disease, there has been greater interest in understanding the basic biology of these human pathogens [5,6]. Recent advances in the field have shown that viral entry of both JCV and BKV is dependent on the ability to interact with sialic acid. This review focuses on what is known about the human polyomaviruses and the role that sialic acid plays in determining viral tropism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575519     DOI: 10.1007/s10719-006-5434-z

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  102 in total

1.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

Review 2.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

3.  Genetic and structural analysis of a virulence determinant in polyomavirus VP1.

Authors:  P H Bauer; R T Bronson; S C Fung; R Freund; T Stehle; S C Harrison; T L Benjamin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Inhibition of BK virus haemagglutination by gangliosides.

Authors:  L Sinibaldi; D Viti; P Goldoni; G Cavallo; C Caroni; N Orsi
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

Review 5.  Role of the environment in the transmission of JC virus.

Authors:  Sílvia Bofill-Mas; Rosina Girones
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

6.  The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells.

Authors:  C K Liu; A P Hope; W J Atwood
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

7.  Conformational changes of murine polyomavirus capsid proteins induced by sialic acid binding.

Authors:  Michaela Cavaldesi; Maddalena Caruso; Olga Sthandier; Paolo Amati; Marie Isabelle Garcia
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

Review 8.  Polyomavirus nephropathy: morphology, pathophysiology, and clinical management.

Authors:  Volker Nickeleit; Harsharan K Singh; Michael J Mihatsch
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-11       Impact factor: 2.894

9.  BK virus antigenic variants: sequence analysis within the capsid VP1 epitope.

Authors:  L Jin; P E Gibson; W A Knowles; J P Clewley
Journal:  J Med Virol       Date:  1993-01       Impact factor: 2.327

10.  Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.

Authors:  P M Chesters; J Heritage; D J McCance
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  10 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 2.  The chemical neurobiology of carbohydrates.

Authors:  Heather E Murrey; Linda C Hsieh-Wilson
Journal:  Chem Rev       Date:  2008-05-02       Impact factor: 60.622

Review 3.  Mechanisms of BK virus infection of renal cells and therapeutic implications.

Authors:  Christiane Mbianda; Ashraf El-Meanawy; Andrey Sorokin
Journal:  J Clin Virol       Date:  2015-08-06       Impact factor: 3.168

4.  The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid.

Authors:  Stephen R Zins; Christian D S Nelson; Melissa S Maginnis; Rahul Banerjee; Bethany A O'Hara; Walter J Atwood
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

5.  Reining in polyoma virus associated nephropathy: design and characterization of a template mimicking BK viral coat protein cellular binding.

Authors:  Christopher O Audu; Bethany O'Hara; Maria Pellegrini; Lei Wang; Walter J Atwood; Dale F Mierke
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

Review 6.  JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.

Authors:  Melissa S Maginnis; Christian D S Nelson; Walter J Atwood
Journal:  J Neurovirol       Date:  2014-07-31       Impact factor: 2.643

7.  An Expeditious Synthesis of Sialic Acid Derivatives by Copper(I)-Catalyzed Stereodivergent Propargylation of Unprotected Aldoses.

Authors:  Xiao-Feng Wei; Yohei Shimizu; Motomu Kanai
Journal:  ACS Cent Sci       Date:  2016-01-04       Impact factor: 14.553

Review 8.  Exploitation of glycosylation in enveloped virus pathobiology.

Authors:  Yasunori Watanabe; Thomas A Bowden; Ian A Wilson; Max Crispin
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-05-20       Impact factor: 3.770

Review 9.  Glycan Nanostructures of Human Coronaviruses.

Authors:  Wanru Guo; Harini Lakshminarayanan; Alex Rodriguez-Palacios; Robert A Salata; Kaijin Xu; Mohamed S Draz
Journal:  Int J Nanomedicine       Date:  2021-07-15

10.  Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.

Authors:  Przemyslaw Wielgat; Karol Rogowski; Katarzyna Godlewska; Halina Car
Journal:  Cells       Date:  2020-08-25       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.